Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04675593 · ClinicalTrials.gov registry record · NA

Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders

A NA study of Hypertension and Major Depressive Disorder, sponsored by Case Western Reserve University.

Active
Registry status
NA
Development phase
176
Enrollment target
1
Study location

NCT04675593 is a NA study of Hypertension and Major Depressive Disorder that is active but no longer recruiting, run by Case Western Reserve University. The registered enrollment target is 176 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04675593, a NA study of Hypertension and Major Depressive Disorder, is active but no longer recruiting, sponsored by Case Western Reserve University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
176 participants
Enrollment target
1
Study location

Study Summary

This proposed 2-stage randomized controlled trial (RCT) will evaluate a personalized patient-centered adherence intervention iTAB-CV + Self-Monitoring (iTAB-CV + SM) vs. Self-Monitoring (SM) alone in poorly adherent hypertensive persons with BD or MDD. This practical, technology-facilitated intervention has potential to improve adherence to antihypertensive medication and reduce SBP among high-risk individuals. The intervention is suitable for primary care or mental health settings and has potential for broad scale-up.

Interventions

  • BEHAVIORAL iTAB-CV
  • BEHAVIORAL Self-Monitoring

Study Locations (1)

Ohio

  • Case Western Reserve University - Cleveland

Trial Details

FieldValue
Enrollment Target 176 participants
Start Date 2021-03-15
Est. Completion 2026-06-01
Phase NA

Sponsor

Case Western Reserve University

141 total trials

What the Registry Record Tells You About NCT04675593

The ClinicalTrials.gov registry entry for NCT04675593 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which iTAB-CV is the first listed.

NCT04675593 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04675593 about?

NCT04675593 is a clinical study titled "Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders". This proposed 2-stage randomized controlled trial (RCT) will evaluate a personalized patient-centered adherence intervention iTAB-CV + Self-Monitoring (iTAB-CV + SM) vs. Self-Monitoring (SM) alone in poorly adherent hypertensive persons with BD or MDD. This practical, technology-facilitated interven...

What is the current status of trial NCT04675593?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 176 participants. The study started on 2021-03-15. Estimated completion is 2026-06-01.

What conditions does trial NCT04675593 study?

This clinical trial studies the following conditions: Hypertension, Major Depressive Disorder, Bipolar Disorder, Non-Adherence, Medication.

What interventions are being tested in trial NCT04675593?

The interventions under investigation include: iTAB-CV (BEHAVIORAL), Self-Monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT04675593?

This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04675593 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.